Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hypoxia D000860 23 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Hypercalcemia D006934 13 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Tumor Virus Infections D014412 8 associated lipids
Adenocarcinoma D000230 166 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Pain D010146 64 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Wounds and Injuries D014947 20 associated lipids
Pleurisy D010998 20 associated lipids
Burns D002056 34 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Retinopathy D003930 39 associated lipids
Infertility, Male D007248 11 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Brain Injuries D001930 4 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Osteonecrosis D010020 5 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Gastritis D005756 27 associated lipids
Pulmonary Edema D011654 23 associated lipids
Coronary Disease D003327 70 associated lipids
Intestinal Obstruction D007415 6 associated lipids
Pancreatitis D010195 10 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Hypersensitivity D006967 22 associated lipids
Osteosarcoma D012516 50 associated lipids
Rhinitis D012220 10 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Abe Y et al. Effect of a platelet-activating factor antagonist, E5880, on cerebrovasospasm following subarachnoid hemorrhage in a canine double-hemorrhage model. 2002 Eur. J. Pharmacol. pmid:12445578
Marathe GK et al. Activation of vascular cells by PAF-like lipids in oxidized LDL. 2002 Vascul. Pharmacol. pmid:12449015
Lacombe J et al. Antisense inhibition of Flk-1 by oligonucleotides composed of 2'-deoxy-2'-fluoro-beta-D-arabino- and 2'-deoxy-nucleosides. 2002 Can. J. Physiol. Pharmacol. pmid:12450061
Roy Baker R and Chang Hy MgATP may depress de novo neuronal nuclear PAF generation by promoting the formation of alkylacylglycerophosphate, an inhibitor of alkylglycerophosphate acetyltransferase. 2002 Biochim. Biophys. Acta pmid:12457714
Akisu M et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the generation of platelet-activating factor and leukotriene B4 in hypoxic-ischemic brain in young mice. 2002 Prostaglandins Leukot. Essent. Fatty Acids pmid:12468264
Huang JB et al. Hexokinase translocation during neutrophil activation, chemotaxis, and phagocytosis: disruption by cytochalasin D, dexamethasone, and indomethacin. 2002 Jul-Aug Cell. Immunol. pmid:12470617
Pan YH et al. Crystal structure of phospholipase A2 complex with the hydrolysis products of platelet activating factor: equilibrium binding of fatty acid and lysophospholipid-ether at the active site may be mutually exclusive. 2002 Biochemistry pmid:12475227
Smith JM et al. Platelet-activating factor and Escherichia coliO157:H7 infections. 2002 Pediatr. Nephrol. pmid:12478356
Makhija R and Kingsnorth AN Cytokine storm in acute pancreatitis. 2002 J Hepatobiliary Pancreat Surg pmid:12483260
Kulikov VI and Muzya GI Influence of acyl and plasmalogenic analogs of platelet activating factor on chemotaxis of human leukocytes in vitro and their inflammatory and antiinflammatory activity in vivo. 2002 Biochemistry Mosc. pmid:12495421
Al-Darmaki S et al. Differential expression of platelet-activating factor acetylhydrolase in macrophages and monocyte-derived dendritic cells. 2003 J. Immunol. pmid:12496397
Saeed SA and Rasheed H Calcium-dependent synergistic interaction of platelet activating factor and epinephrine in human platelet aggregation. 2003 Acta Pharmacol. Sin. pmid:12511226
Francescangeli E et al. Activation of PAF-synthesizing enzymes in rat brain stem slices after LTP induction in the medial vestibular nuclei. 2002 Neurochem. Res. pmid:12512951
Zhang Y et al. Antioxidant superoxide dismutase attenuates increased endothelial permeability induced by platelet-activating factor. 2003 J. Soc. Gynecol. Investig. pmid:12517587
Wang WJ et al. [Effects of musk glucoprotein on PAF production and cytosolic Ca2+ level in rat polymorphonuclear leukocytes in vitro]. 2000 Zhongguo Zhong Yao Za Zhi pmid:12525061
Handa RK et al. Platelet-activating factor and solute transport processes in the kidney. 2003 Am. J. Physiol. Renal Physiol. pmid:12529272
Zhao H et al. Influence of platelet activating factor on expression of adhesion molecules in experimental pancreatitis. 2003 World J. Gastroenterol. pmid:12532462
Bussolati B et al. The long pentraxin PTX3 is synthesized in IgA glomerulonephritis and activates mesangial cells. 2003 J. Immunol. pmid:12538709
Furukawa M et al. Presence of platelet-activating factor in nasal polyps and eosinophils. 2002 Acta Otolaryngol. pmid:12542208
Hirayama K et al. Platelet-activating factor, a critical mediator in the pathogenesis of dextran sulfate sodium-induced colitis in rats. 2003 Dis. Colon Rectum pmid:12544529
Farmer PJ et al. Inhibition of prostaglandin G/H synthase unveils a potent effect of platelet activating factor on the permeability of bovine aortic endothelial cells to albumin. 2002 Inflammation pmid:12546134
Jin Y et al. [The effect of autocrine factors on development of early embryos of mouse]. 2001 Shi Yan Sheng Wu Xue Bao pmid:12549014
Wang R et al. [High performance thin layer chromatographic (HPTLC) determination of PAF in cerebrospinal fluid of patients with subarachnoid hemorrhage(SAH)]. 1999 Se Pu pmid:12552702
Lee JM et al. Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis. 2003 J. Biol. Chem. pmid:12556532
Rios-Santos F et al. A critical role of leukotriene B4 in neutrophil migration to infectious focus in cecal ligaton and puncture sepsis. 2003 Shock pmid:12558146
Kolko M et al. Neuronal damage by secretory phospholipase A2: modulation by cytosolic phospholipase A2, platelet-activating factor, and cyclooxygenase-2 in neuronal cells in culture. 2003 Neurosci. Lett. pmid:12566178
Vogensen SB et al. Preparation of 7-substituted ginkgolide derivatives: potent platelet activating factor (PAF) receptor antagonists. 2003 J. Med. Chem. pmid:12570381
Tselepis AD and John Chapman M Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase. 2002 Atheroscler Suppl pmid:12573364
Balestrieri ML et al. Modulation by flavonoids of PAF and related phospholipids in endothelial cells during oxidative stress. 2003 J. Lipid Res. pmid:12576520
Chen WM et al. [Experimental study on inhibitory effect of rutin against platelet activation induced by platelet activating factor in rabbits]. 2002 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:12584792
Diez-Fraile A et al. Analysis of selective mobilization of L-selectin and Mac-1 reservoirs in bovine neutrophils and eosinophils. 2003 Jan-Feb Vet. Res. pmid:12588684
Gabbianelli R et al. A new method to evaluate spontaneous platelet aggregation in type 2 diabetes by Cellfacts. 2003 Clin. Chim. Acta pmid:12589971
Chłopicki S et al. Hypoxic pulmonary vasoconstriction in isolated blood-perfused rat lung; modulation by thromboxane A2, platelet-activating factor, cysteinyl leukotrienes and endothelin-1. 2002 Sep-Oct Pol J Pharmacol pmid:12593530
Biffl WL et al. Neutrophil apoptosis is delayed by trauma patients' plasma via a mechanism involving proinflammatory phospholipids and protein kinase C. 2001 Surg Infect (Larchmt) pmid:12593704
Casillan AJ et al. Mesenteric microvascular inflammatory responses to systemic hypoxia are mediated by PAF and LTB4. 2003 J. Appl. Physiol. pmid:12598480
D'Andrea G et al. Platelet aggregation profiles in cluster headache. 2003 Headache pmid:12603647
Gruska S et al. Sodium/lithium countertransport and intracellular calcium concentration in patients with essential hypertension and coronary heart disease. 2003 Clin. Sci. pmid:12605593
Lu DP et al. Ligand-activated signal transduction in the 2-cell embryo. 2003 Biol. Reprod. pmid:12606379
Hu G et al. Neutrophils pretreated with volatile anesthetics lose ability to cause cardiac dysfunction. 2003 Anesthesiology pmid:12606916
Corl CM et al. Oxidant stress enhances Lyso-PAF-AcT activity by modifying phospholipase D and phosphatidic acid in aortic endothelial cells. 2003 Biochem. Biophys. Res. Commun. pmid:12615078
Hynes AC et al. The phosphatidylinositol signalling system in elongating bovine blastocysts; formation of phosphoinositides, inositol phosphates and stimulation by growth factors. 2002 Reprod. Fertil. Dev. pmid:12617797
Hou X et al. Increased platelet-activating factor-induced periventricular brain microvascular constriction associated with immaturity. 2003 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:12626359
Triggiani M et al. Secretory phospholipases A2 activate selective functions in human eosinophils. 2003 J. Immunol. pmid:12626587
Proudfoot JM et al. Angiotensin II type 1 receptor antagonists inhibit basal as well as low-density lipoprotein and platelet-activating factor-stimulated human monocyte chemoattractant protein-1. 2003 J. Pharmacol. Exp. Ther. pmid:12626661
Fang HY et al. Cyclooxygenase-2 in human non-small cell lung cancer. 2003 Eur J Surg Oncol pmid:12633561
Ueyama Y et al. Effects of bile acids on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced aberrant crypt foci and DNA adduct formation in the rat colon. 2002 J. Exp. Clin. Cancer Res. pmid:12636105
Strait RT et al. IL-4 exacerbates anaphylaxis. 2003 J. Immunol. pmid:12646651
Adamson RH et al. PAF- and bradykinin-induced hyperpermeability of rat venules is independent of actin-myosin contraction. 2003 Am. J. Physiol. Heart Circ. Physiol. pmid:12649070
Haraldsen P et al. Multimodal management - of value in fulminant acute pancreatitis? 2003 Pancreatology pmid:12649560
Shigematsu S et al. Resveratrol, a red wine constituent polyphenol, prevents superoxide-dependent inflammatory responses induced by ischemia/reperfusion, platelet-activating factor, or oxidants. 2003 Free Radic. Biol. Med. pmid:12654468
Simon HU et al. Interleukin-2 primes eosinophil degranulation in hypereosinophilia and Wells' syndrome. 2003 Eur. J. Immunol. pmid:12672048
Teather LA and Wurtman RJ Cyclooxygenase-2 mediates platelet-activating factor-induced prostaglandin E2 release from rat primary astrocytes. 2003 Neurosci. Lett. pmid:12672535
Kordan W et al. Functions of platelet activating factor (PAF) in mammalian reproductive processes: a review. 2003 Pol J Vet Sci pmid:12675470
Loucks EB et al. Role of platelet activating factor in cardiac dysfunction, apoptosis and nitric oxide synthase mRNA expression in the ischemic-reperfused rabbit heart. 2003 Can J Cardiol pmid:12677282
Mariano F et al. Platelet-activating factor synthesis by neutrophils, monocytes, and endothelial cells is modulated by nitric oxide production. 2003 Shock pmid:12688545
Thaete LG et al. Infusion of exogenous platelet-activating factor produces intrauterine growth restriction in the rat. 2003 J. Soc. Gynecol. Investig. pmid:12699876
Wu B et al. Platelet-activating factor promotes mucosal apoptosis via FasL-mediating caspase-9 active pathway in rat small intestine after ischemia-reperfusion. 2003 FASEB J. pmid:12709415
Chmiel B [The influence of select pathophysiologic factors of acute pancreatitis on erythrocytes' deformability examined in vitro]. 2002 Wiad. Lek. pmid:12715347
Guan Z et al. [Role of interleukin-6 and platelet-activating factor in delaying neutrophil apoptosis]. 2000 Wei Sheng Yan Jiu pmid:12725051
Mahgoub AA Thymoquinone protects against experimental colitis in rats. 2003 Toxicol. Lett. pmid:12749817
Marshall JC Such stuff as dreams are made on: mediator-directed therapy in sepsis. 2003 Nat Rev Drug Discov pmid:12750742
Ginesta MM et al. Modulation of the pathology of late xenograft rejection by PAF-antagonist UR-12670 in the hamster-to-rat liver xenotransplant model. 2003 APMIS pmid:12752216
Kusunoki H et al. Relation between serum 3-deoxyglucosone and development of diabetic microangiopathy. 2003 Diabetes Care pmid:12766129
Strümper D et al. Effects of antidepressants on function and viability of human neutrophils. 2003 Anesthesiology pmid:12766643
Pizurki L et al. Angiopoietin-1 inhibits endothelial permeability, neutrophil adherence and IL-8 production. 2003 Br. J. Pharmacol. pmid:12770938
Takizawa T et al. Distinct isoforms of protein kinase C are involved in human eosinophil functions induced by platelet-activating factor. 2003 Int. Arch. Allergy Immunol. pmid:12771544
Denizot Y et al. No evidence for a putative involvement of platelet-activating factor in systemic lupus erythematosus without active nephritis. 2003 Mediators Inflamm. pmid:12775360
Yan W et al. Previously uncharacterized roles of platelet-activating factor acetylhydrolase 1b complex in mouse spermatogenesis. 2003 Proc. Natl. Acad. Sci. U.S.A. pmid:12775763
Nie ZG and Wang WJ [Effect of ginkgolide B on platelet-activating factor induced activation of rat polymorphonuclear leukocytes]. 2003 Yao Xue Xue Bao pmid:12778742
Sugimoto Y et al. Inhibitory effects of glucocorticoids on rat eosinophil superoxide generation and chemotaxis. 2003 Int. Immunopharmacol. pmid:12781701
Fragopoulou E et al. Structure elucidation of phenolic compounds from red/white wine with antiatherogenic properties. 2003 Biochim. Biophys. Acta pmid:12782155
Baltás E et al. Platelet-activating factor antagonist WEB 2086 inhibits ultraviolet-B radiation-induced dermatitis in the human skin. 2003 Jul-Aug Skin Pharmacol. Appl. Skin Physiol. pmid:12784066
Witko-Sarsat V et al. AOPP-induced activation of human neutrophil and monocyte oxidative metabolism: a potential target for N-acetylcysteine treatment in dialysis patients. 2003 Kidney Int. pmid:12787398
Slomiany BL and Slomiany A Platelet-activating factor modulates gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide. 2003 Biochem. Biophys. Res. Commun. pmid:12788098
Schuster DP et al. Recombinant platelet-activating factor acetylhydrolase to prevent acute respiratory distress syndrome and mortality in severe sepsis: Phase IIb, multicenter, randomized, placebo-controlled, clinical trial. 2003 Crit. Care Med. pmid:12794395
Rabinovici R Platelet activating factor inhibition in sepsis: the end? 2003 Crit. Care Med. pmid:12794432
Mentz P et al. Interactions of prostanoids with the platelet activating factors. 1992 Prostaglandins Leukot. Essent. Fatty Acids pmid:1279731
Saraf MK et al. Role of platelet activating factor in triazolobenzodiazepines-induced retrograde amnesia. 2003 Behav. Brain Res. pmid:12798263
Boughton-Smith NK et al. Actions of nitric oxide on the acute gastrointestinal damage induced by PAF in the rat. 1992 Agents Actions pmid:1279960
Hashimoto T et al. [Effect of tazanolast on platelet activating factor-induced airway hyperresponsiveness in guinea pigs]. 1992 Arerugi pmid:1280089
Underwood SL et al. RP 58802B, a long-acting beta 2-adrenoceptor agonist: assessment of antiasthma activity in the guinea-pig in vivo. 1992 Pulm Pharmacol pmid:1280178
Denizot Y et al. Platelet-activating factor and normal or leukaemic haematopoiesis. 2003 Leuk. Lymphoma pmid:12802913
Vleeming W et al. Modulation of antigen- and ischemia-induced effects by the platelet-activating factor antagonist WEB-2086 in isolated sensitized rat hearts. 1992 J. Cardiovasc. Pharmacol. pmid:1280743
Fernandes LB and Goldie RG The single mediator approach to asthma therapy: is it so unreasonable? 2003 Curr Opin Pharmacol pmid:12810188
Watanabe J et al. Endotoxins stimulate neutrophil adhesion followed by synthesis and release of platelet-activating factor in microparticles. 2003 J. Biol. Chem. pmid:12810708
Toledo AA et al. Fertilization potential of human sperm is correlated with endogenous platelet-activating factor content. 2003 J. Assist. Reprod. Genet. pmid:12812462
Souza DG et al. Role of PAF receptors during intestinal ischemia and reperfusion injury. A comparative study between PAF receptor-deficient mice and PAF receptor antagonist treatment. 2003 Br. J. Pharmacol. pmid:12812996
Brown RA et al. Effects of heparin and related molecules upon neutrophil aggregation and elastase release in vitro. 2003 Br. J. Pharmacol. pmid:12813008
Abu-Zidan FM Comment on "Low-dose ethanol alters the cardiovascular, metabolic, and respiratory compensation for severe blood loss". 2003 J Trauma pmid:12813357
Toledo DP et al. Microvascular reactivity in experimental diabetes: responses of male and female rats. 2003 Inflamm. Res. pmid:12813623
Hellewell PG et al. Inflammatory mechanisms in the passive cutaneous anaphylactic reaction in the rabbit: evidence that novel mediators are involved. 1992 Br. J. Pharmacol. pmid:1281720
Sugimoto T et al. Molecular cloning and characterization of the platelet-activating factor receptor gene expressed in the human heart. 1992 Biochem. Biophys. Res. Commun. pmid:1281995
Olanders K et al. Protective effects of N-acetyl-L-cysteine and platelet activating factor inhibition are not linked to intercellular adhesion molecule-1 expression after intestinal ischemia and reperfusion injury in rats. 2003 Scand. J. Gastroenterol. pmid:12825870
Black SC et al. Inhibition of platelet-activating factor fails to limit ischemia and reperfusion-induced myocardial damage. 1992 J. Cardiovasc. Pharmacol. pmid:1282605
Sagach VF et al. Endothelium-dependent effects of platelet-activating factor in the coronary circulation. 1992 J. Cardiovasc. Pharmacol. pmid:1282996
Tonks AJ et al. Regulation of platelet-activating factor synthesis in human monocytes by dipalmitoyl phosphatidylcholine. 2003 J. Leukoc. Biol. pmid:12832447
Choi IW et al. Platelet-activating factor-mediated NF-kappaB dependency of a late anaphylactic reaction. 2003 J. Exp. Med. pmid:12835479
Fernandes ES et al. Mechanisms underlying the modulatory action of platelet activating factor (PAF) on the upregulation of kinin B1 receptors in the rat paw. 2003 Br. J. Pharmacol. pmid:12839871
Neumann FJ et al. Effect of gallopamil on neutrophil function: experimental and clinical studies. 1992 J. Cardiovasc. Pharmacol. pmid:1284152
Saruc M et al. An experimental model of hemolysis-induced acute pancreatitis. 2003 Braz. J. Med. Biol. Res. pmid:12845374